+91-9660032889
+91-9660032889
support@mysiponline.com
WhiteOak Capital Pharma and Healthcare Fund - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Very High
-
₹12.7
(0.95%)
Current NAV 17-04-2025
-
26.81%
Returns
-
Min. SIP ₹100
Min. Investment ₹500
Fund Suitability Test
Asset Allocation (As on 31-Jan-2025)
Allocation of Equity and Debt Asset Classes.
- Equity 92.28%
- Debt 3.37%
- Others 4.35%
Market Cap Allocation Of Equity
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Small Cap | 32.62 |
| Mid Cap | 29.67 |
| Large Cap | 26.29 |
| Others | 3.69 |
Sector Allocation of Equity
Weightage of Portfolio Among Different Sectors.
Healthcare
Basic Materials
Financial Services
Current Stocks Holdings of Equity
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 17-Apr-2025 |
Holdings | PE Ratio 17-Apr-2025 |
1Y Return |
|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Large Cap | Healthcare (45.54) | 10.33% | 36.74 | 13.99% |
| Cipla Ltd | Large Cap | Healthcare (45.54) | 7% | 24.53 | 10.13% |
| Max Healthcare Institute Ltd Ordinary Shares | Mid Cap | Healthcare (98.69) | 6.93% | 104.61 | 32.62% |
| Divi's Laboratories Ltd | Large Cap | Healthcare (45.59) | 6.18% | 73.98 | 53.01% |
| Lupin Ltd | Mid Cap | Healthcare (132.95) | 4.95% | 167.31 | 197.56% |
| Krishna Institute of Medical Sciences Ltd | Small Cap | Healthcare | 3.5% | - | 0% |
| Fortis Healthcare Ltd | Mid Cap | Healthcare (98.69) | 3.4% | 64.94 | 50.03% |
| Apollo Hospitals Enterprise Ltd | Mid Cap | Healthcare (98.69) | 3.01% | 77.54 | 11.54% |
| Torrent Pharmaceuticals Ltd | Large Cap | Healthcare (45.54) | 2.78% | 59.15 | 28.29% |
| Glenmark Pharmaceuticals Ltd | Mid Cap | Healthcare (45.54) | 2.34% | -215.35 | 26.62% |
| Piramal Pharma Ltd | Small Cap | Healthcare (22.59) | 2.23% | 0 | -26.02% |
| Laurus Labs Ltd | Small Cap | Healthcare (46.65) | 2.18% | 0 | 9.05% |
| Ipca Laboratories Ltd | Mid Cap | Healthcare (45.54) | 2.1% | 48.59 | 4.12% |
| Laxmi Dental Ltd | Healthcare | 2.02% | - | 0% | |
| Biocon Ltd | Mid Cap | Healthcare (45.54) | 2% | 49.39 | 25.77% |
| Poly Medicure Ltd | Small Cap | Healthcare (69.09) | 1.93% | 74.79 | 48.38% |
| Aster DM Healthcare Ltd Ordinary Shares | Small Cap | Healthcare (98.69) | 1.61% | 4.73 | -3.9% |
| Mankind Pharma Ltd | Mid Cap | Healthcare (45.54) | 1.59% | 52.2 | 13.17% |
| Vijaya Diagnostic Centre Ltd | Small Cap | Healthcare (98.69) | 1.59% | 75.62 | 52.59% |
| Neuland Laboratories Limited | Small Cap | (45.54) | 1.59% | 54.99 | 70.91% |
| Navin Fluorine International Ltd | Small Cap | Basic Materials (26.29) | 1.5% | 0 | 6.43% |
| Jupiter Life Line Hospitals Ltd | Small Cap | Healthcare | 1.5% | - | 0% |
| Ajanta Pharma Ltd | Mid Cap | Healthcare (45.54) | 1.45% | 37.42 | 30.24% |
| Aurobindo Pharma Ltd | Mid Cap | Healthcare (45.54) | 1.41% | 19.51 | 5.65% |
| Global Health Ltd | Small Cap | Healthcare (98.69) | 1.31% | 67.13 | -8.72% |
| Ami Organics Ltd | Small Cap | Basic Materials (45.54) | 1.2% | 78.37 | 89.17% |
| Blue Jet Healthcare Ltd | Small Cap | Healthcare (44.73) | 1.13% | 0 | 61.48% |
| OneSource Specialty Pharma Ltd | Healthcare | 1.13% | - | 0% | |
| Rainbow Childrens Medicare Ltd | Small Cap | Healthcare (98.69) | 1.12% | 64.07 | 14.36% |
| Strides Pharma Science Ltd | Small Cap | Healthcare (45.54) | 1.12% | 22.22 | -22.38% |
| Supriya Lifescience Ltd | Small Cap | Healthcare (29.86) | 1.1% | 0 | 0% |
| Kovai Medical Center & Hospital Ltd | Small Cap | Healthcare (98.69) | 1.1% | 0 | 40.34% |
| Shaily Engineering Plastics Ltd | Small Cap | Basic Materials (35.81) | 1% | 100.44 | 205.75% |
| Eris Lifesciences Ltd Registered Shs | Small Cap | Healthcare (45.54) | 0.99% | 57.12 | 59.26% |
| Shilpa Medicare Ltd | Small Cap | Healthcare (45.59) | 0.78% | 72.92 | 21.84% |
| Vimta Labs Ltd | Small Cap | Healthcare (62.44) | 0.77% | 34.87 | 108.99% |
| Sai Life Sciences Ltd | Small Cap | Healthcare | 0.74% | - | 0% |
| Thyrocare Technologies Ltd | Small Cap | Healthcare (89.78) | 0.7% | 43.66 | 12.6% |
| Gufic Biosciences Ltd | Small Cap | Healthcare (55.16) | 0.66% | 36 | 45.63% |
| Jagsonpal Pharmaceuticals Ltd | Healthcare | 0.54% | - | 0% | |
| RPG Life Sciences Ltd | Small Cap | Healthcare (55.16) | 0.54% | 29.33 | 90% |
| PB Fintech Ltd | Mid Cap | Financial Services (76.58) | 0.49% | 615.37 | 84.19% |
| Zota Health Care Ltd | Small Cap | Healthcare | 0.4% | - | 0% |
| Dr Agarwal'S Eye Hospital Ltd | Small Cap | Healthcare (98.69) | 0.35% | 0 | 23.17% |
| Dr Reddy's Laboratories Ltd | Large Cap | Healthcare | 0% | - | 0% |
| J.B. Chemicals & Pharmaceuticals Ltd | Small Cap | Healthcare (55.16) | 0% | 48.39 | 61.86% |
| Medplus Health Services Ltd | Small Cap | Healthcare (45.54) | 0% | 71.76 | 14.9% |
Discover More with Premium Access
View Stock InformationMarket Cap Allocation Of Debt
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Others | 3.37 |
Sector Allocation of Debt
Weightage of Portfolio Among Different Sectors.
Current Stocks Holdings of Debt
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 01-Jan-1970 |
Holdings | PE Ratio 01-Jan-1970 |
1Y Return |
|---|---|---|---|---|---|
| 182 D Tbill Mat - 14/02/2025 | 1.05% | - | 0% | ||
| 91 Days Tbill Red 27-02-2025 | 0.7% | - | 0% | ||
| 91 DTB 20032025 | 0.35% | - | 0% | ||
| 91 DTB 10042025 | 0.35% | - | 0% | ||
| 91 DTB 17042025 | 0.35% | - | 0% | ||
| 182 DTB 20022025 | 0.31% | - | 0% | ||
| 91 Days Tbill Red 24-04-2025 | 0.17% | - | 0% | ||
| 364 DTB 13032025 | 0.07% | - | 0% | ||
| 91 DTB 28032025 | 0.03% | - | 0% | ||
| 364 DTB 09012025 | 0% | - | 0% | ||
| 364 DTB 02052024 | 0% | - | 0% | ||
| 364 Day T-Bill 30.01.25 | 0% | - | 0% |
Discover More with Premium Access
View Stock InformationMarket Cap Allocation Of Others
Shows Distribution among Different Size Companies.
| Category | Allocation |
|---|---|
| Others | 4.35 |
Sector Allocation of Others
Weightage of Portfolio Among Different Sectors.
Current Stocks Holdings of Others
Information on Stock Holdings in Portfolio
| Stocks | Market Cap | Sectors (PE Ratio) 01-Jan-1970 |
Holdings | PE Ratio 01-Jan-1970 |
1Y Return |
|---|---|---|---|---|---|
| Clearing Corporation Of India Ltd | 3.51% | - | 0% | ||
| Net Receivables / (Payables) | 0.84% | - | 0% |
Discover More with Premium Access
View Stock Information
Take test again
Chat with usFrequently Asked Questions
What is Market cap allocation in the portfolio?
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.
Top 5 holdings for WhiteOak Capital Pharma and Healthcare Fund?
The top holdings of this fund are
How do I create a good mutual fund portfolio?
Building a good portfolio requires proper research and knowing about goals that need to be achieved. Set a boundary for your risk capacity, study about different funds and look at its past performance. Balance portfolio according to set goals and stay informed.
How to maintain a good portfolio?
Timely monitoring of the portfolio keeps us aware of the changes in the ongoing market trends. It helps in making plans for any policy change.
What is sector allocation in the portfolio?
The distribution of assets among various economic sectors is referred to as sector allocation in a portfolio. These sectors include technology, healthcare, financial, energy, and many others.
Top 5 Sector for WhiteOak Capital Pharma and Healthcare Fund?
The major sectors of this fund are .
What is the ideal number of funds to have in a portfolio?
There is no ideal number, but it is always advisable to keep 4-5 funds in the portfolio as it can be easy to manage them and correct decisions can be taken according to it. Diversification is the key to manage and balance your portfolio for smooth growth.
How does risk tolerance play a role in determining portfolio allocation?
Risk tolerance is an important factor in maintaining portfolio allocation. With the correct mix of assets, the value of investments can improve significantly.
